DocGo (DCGO) Stock Price, News & Analysis

Company Overview

DocGo Inc. (NASDAQ: DCGO) is a healthcare services and technology company that delivers medical care and transportation outside traditional clinical settings. Its platform combines mobile clinical services, technology-enabled care coordination and non-emergency medical transportation to help healthcare providers, government agencies, insurers and employers serve patients in their homes and communities.

The company’s services include ambulance and non-emergency medical transportation, mobile primary and urgent care, remote patient monitoring, diagnostic testing, vaccination programs and community-based healthcare. DocGo also provides health screening and workforce health services, as well as logistics and medical support for public-sector and emergency-response programs.

DocGo was originally established as Ambulnz and adopted the DocGo name following its business combination with Motion Acquisition Corp. in 2021. The company primarily serves customers and patients in the United States, with operations and service capabilities that have also included the United Kingdom. Its offerings are designed to extend healthcare access beyond hospitals and clinics while supporting more coordinated and efficient patient care.

Key Stats

• Today's Range: $0.36 to $0.37
• 50-Day Range: $0.35 to $0.71
• 52-Week Range: $0.34 to $1.65
• Volume: 148,478 shs
• Average Volume: 602,769 shs
• Market Capitalization: $35.83 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $2.38
• Consensus Rating: Hold

DocGo Stock Analysis - MarketRank™

DocGo scored higher than 50% of companies evaluated by MarketBeat, and ranked 495th out of 901 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.8 / 5
• Analyst Rating: Hold

Consensus Rating

DocGo has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 3 buy ratings, 2 hold ratings, and 1 sell rating.

Upside Potential

DocGo has a consensus price target of $2.38, representing about 555.7% upside from its current price of $0.36.

Amount of Analyst Coverage

DocGo has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for DocGo are expected to grow in the coming year, from ($0.22) to ($0.06) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of DocGo is -0.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of DocGo is -0.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

DocGo has a P/B Ratio of 0.28. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.48% of the float of DocGo has been sold short.

Short Interest Ratio / Days to Cover

DocGo has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in DocGo has recently increased by 5.12%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

DocGo does not currently pay a dividend.

Dividend Growth

DocGo does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 2 news articles for DocGo this week, compared to 2 articles on an average week.

Company Ownership

• Score: 0.9 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, DocGo insiders have not sold or bought any company stock.

Percentage Held by Insiders

5.10% of the stock of DocGo is held by insiders.

Percentage Held by Institutions

56.44% of the stock of DocGo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/17/2026
• Today: 9/24/2026
• Investor update: 9/29/2026
• Next Earnings (Estimated): 11/09/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:DCGO
• CIK: 1822359
• Web: www.docgo.com
• Phone: 844-443-6246
• Fax: N/A
• Employees: 3,568
• Year Founded: N/A

Price Target and Rating

• Average Price Target for DocGo: $2.38
• High Price Target: $3.00
• Low Price Target: $1.00
• Potential Upside/Downside: +555.7%
• Consensus Rating: Hold
• Rating Score (0-4): 2.33
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.96)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$182.40 million
• Net Margins: -65.29%
• Pretax Margin: -64.26%
• Return on Equity: -40.42%
• Return on Assets: -24.81%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.66
• Quick Ratio: 1.66

Sales & Book Value

• Annual Sales: $322.20 million
• Price / Sales: 0.11
• Cash Flow: $0.06 per share
• Price / Cash Flow: 6.48
• Book Value: $1.28 per share
• Price / Book: 0.28

Miscellaneous

• Outstanding Shares: 98,930,000
• Free Float: 93,883,000
• Market Cap: $35.83 million
• Optionable: Optionable
• Beta: 0.94